{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "ae34d96d",
   "metadata": {},
   "source": [
    "# Treatment NER\n",
    "\n",
    "GOAL: Get treatments out of all descriptions accurately \n",
    "\n",
    "### Rough Steps\n",
    "- Get new training set with real data from mediBoard\n",
    "- Train BERT off of training seet\n",
    "- SoftMatch matches to existing treatments from studies\n",
    "- Pack it all together"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "f375528d",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "7c37268e",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sqlalchemy import create_engine\n",
    "\n",
    "db = create_engine(\"postgresql://meditreats:meditreats@df-treats-db.cs6hxh6ocizm.us-west-2.rds.amazonaws.com:5432/meditreats\")\n",
    "\n",
    "connection = db.connect()\n",
    "\n",
    "labels = pd.read_sql_query(\"select * from administrations join groups on administrations.group = groups.id join treatments on administrations.treatment = treatments.id where groups.annotated=true\", connection)\n",
    "\n",
    "labels[['title', 'description', 'name', 'study_id', 'study']].sort_values('study').to_csv('admin_labels.csv')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7640b880",
   "metadata": {},
   "source": [
    "## GPT-3\n",
    "- Let's see if it can do it"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 181,
   "id": "7f102c7c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2"
      ]
     },
     "execution_count": 181,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Let's connect to the API\n",
    "Secret = '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'\n",
    "import os\n",
    "import openai\n",
    "openai.organization = \"org-j6fGVx3OgjgpAbCQFHOmdEUe\"\n",
    "openai.api_key = Secret\n",
    "len(openai.Model.list())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "id": "0df80a6e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>Treatment</th>\n",
       "      <th>Dosage</th>\n",
       "      <th>description</th>\n",
       "      <th>study_id</th>\n",
       "      <th>study</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Clobazam High Dose</td>\n",
       "      <td>Clobazam</td>\n",
       "      <td>5 to 40 mg</td>\n",
       "      <td>5 to 40 mg/day with doses in the morning and a...</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT00162981</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Clobazam Low Dose</td>\n",
       "      <td>Clobazam</td>\n",
       "      <td>5 to 10 mg</td>\n",
       "      <td>5 to 10 mg/day with doses in the morning and a...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT00162981</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Intranasal Midazolam</td>\n",
       "      <td>Midazolam</td>\n",
       "      <td>0.2 mg</td>\n",
       "      <td>0.2 mg/kg Intranasal Midazolam for a seizure l...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT00326612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Intranasal Midazolam</td>\n",
       "      <td>Midazolam</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients who required oxygen at discharge from...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT00326612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Rectal Diazepam</td>\n",
       "      <td>Diazepam</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Includes intubation</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT00326612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>Pembrolizumab + Epacadostat</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>200 mg</td>\n",
       "      <td>Participants received pembrolizumab 200 mg as ...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT03322540</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients receiving celebrex preoperative and p...</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients receiving scheduled ketorolac postope...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Participants</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Participants</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>278 rows Ã— 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                           title      Treatment      Dosage  \\\n",
       "0             Clobazam High Dose       Clobazam  5 to 40 mg   \n",
       "1              Clobazam Low Dose       Clobazam  5 to 10 mg   \n",
       "2           Intranasal Midazolam      Midazolam      0.2 mg   \n",
       "3           Intranasal Midazolam      Midazolam         NaN   \n",
       "4                Rectal Diazepam       Diazepam         NaN   \n",
       "..                           ...            ...         ...   \n",
       "273  Pembrolizumab + Epacadostat  Pembrolizumab      200 mg   \n",
       "274                    Celecoxib      Celecoxib         NaN   \n",
       "275                    Ketorolac      Ketorolac         NaN   \n",
       "276                    Celecoxib      Celecoxib         NaN   \n",
       "277                    Ketorolac      Ketorolac         NaN   \n",
       "\n",
       "                                           description study_id        study  \n",
       "0    5 to 40 mg/day with doses in the morning and a...    OG001  NCT00162981  \n",
       "1    5 to 10 mg/day with doses in the morning and a...    OG000  NCT00162981  \n",
       "2    0.2 mg/kg Intranasal Midazolam for a seizure l...    OG000  NCT00326612  \n",
       "3    Patients who required oxygen at discharge from...    OG000  NCT00326612  \n",
       "4                                  Includes intubation    OG001  NCT00326612  \n",
       "..                                                 ...      ...          ...  \n",
       "273  Participants received pembrolizumab 200 mg as ...    OG000  NCT03322540  \n",
       "274  Patients receiving celebrex preoperative and p...    OG001  NCT03331315  \n",
       "275  Patients receiving scheduled ketorolac postope...    OG000  NCT03331315  \n",
       "276                                       Participants    OG001  NCT03331315  \n",
       "277                                       Participants    OG000  NCT03331315  \n",
       "\n",
       "[278 rows x 6 columns]"
      ]
     },
     "execution_count": 114,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load up the labeled data\n",
    "labeled_admins = pd.read_csv('admin_labels_labeled.csv')\n",
    "labeled_admins = labeled_admins.drop(labeled_admins.columns[0], axis=1).fillna(value='NaN')\n",
    "labeled_admins"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "id": "3685f16b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# pair each treatment with its dose\n",
    "labeled_admins['treat_and_dose'] = labeled_admins['Treatment'] + ' @ ' + labeled_admins['Dosage']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "id": "e5c2d809",
   "metadata": {},
   "outputs": [],
   "source": [
    "labeled_admins = labeled_admins.groupby(['title', 'description', 'study_id', 'study']).agg({\n",
    "    'treat_and_dose': lambda x: ' \\n\\n '.join(x),\n",
    "}).reset_index()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "id": "be3b43bc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>description</th>\n",
       "      <th>study_id</th>\n",
       "      <th>study</th>\n",
       "      <th>treat_and_dose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.1 g/kg Octagam 10% Every 2 Weeks</td>\n",
       "      <td>Participants received 0.1 g/kg octagam 10% int...</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT00812565</td>\n",
       "      <td>Octagam @ 0.1 g/kg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.2 g/kg Octagam 10% Every 4 Weeks</td>\n",
       "      <td>Participants received 0.2 g/kg octagam 10% int...</td>\n",
       "      <td>OG005</td>\n",
       "      <td>NCT00812565</td>\n",
       "      <td>Octagam @ 0.2 g/kg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.25 g/kg Octagam 10% Every 2 Weeks</td>\n",
       "      <td>Participants received 0.25 g/kg octagam 10% ev...</td>\n",
       "      <td>OG002</td>\n",
       "      <td>NCT00812565</td>\n",
       "      <td>Octagam @ 0.25 g/kg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.4 g/kg Octagam 10% Every 2 Weeks</td>\n",
       "      <td>Participants received of 0.4 g/kg octagam 10% ...</td>\n",
       "      <td>OG003</td>\n",
       "      <td>NCT00812565</td>\n",
       "      <td>Octagam @ 0.4 g/kg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.5 g/kg Octagam 10% Every 4 Weeks</td>\n",
       "      <td>Participants received 0.5 g/kg octagam 10% eve...</td>\n",
       "      <td>OG006</td>\n",
       "      <td>NCT00812565</td>\n",
       "      <td>Octagam @ 0.5 g/kg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>Warfarin</td>\n",
       "      <td>Subjects assigned to warfarin therapy.\\n\\nWarf...</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT01182441</td>\n",
       "      <td>Warfarin @ NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>Warfarin/Placebo Edoxaban</td>\n",
       "      <td>Warfarin tablets plus placebo Edoxaban tablets...</td>\n",
       "      <td>OG002</td>\n",
       "      <td>NCT00781391</td>\n",
       "      <td>Placebo @ NaN \\n\\n Warfarin @ NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>ZOMIG 0.5 mg</td>\n",
       "      <td>ZOMIG nasal spray</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT01211145</td>\n",
       "      <td>Zomig @ 0.5 mg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>ZOMIG 2.5 mg</td>\n",
       "      <td>ZOMIG nasal spray</td>\n",
       "      <td>OG002</td>\n",
       "      <td>NCT01211145</td>\n",
       "      <td>Zomig @ 2.5 mg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>ZOMIG 5 mg</td>\n",
       "      <td>ZOMIG nasal spray</td>\n",
       "      <td>OG003</td>\n",
       "      <td>NCT01211145</td>\n",
       "      <td>Zomig @ 5 mg</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>191 rows Ã— 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                   title  \\\n",
       "0     0.1 g/kg Octagam 10% Every 2 Weeks   \n",
       "1     0.2 g/kg Octagam 10% Every 4 Weeks   \n",
       "2    0.25 g/kg Octagam 10% Every 2 Weeks   \n",
       "3     0.4 g/kg Octagam 10% Every 2 Weeks   \n",
       "4     0.5 g/kg Octagam 10% Every 4 Weeks   \n",
       "..                                   ...   \n",
       "186                             Warfarin   \n",
       "187            Warfarin/Placebo Edoxaban   \n",
       "188                         ZOMIG 0.5 mg   \n",
       "189                         ZOMIG 2.5 mg   \n",
       "190                           ZOMIG 5 mg   \n",
       "\n",
       "                                           description study_id        study  \\\n",
       "0    Participants received 0.1 g/kg octagam 10% int...    OG001  NCT00812565   \n",
       "1    Participants received 0.2 g/kg octagam 10% int...    OG005  NCT00812565   \n",
       "2    Participants received 0.25 g/kg octagam 10% ev...    OG002  NCT00812565   \n",
       "3    Participants received of 0.4 g/kg octagam 10% ...    OG003  NCT00812565   \n",
       "4    Participants received 0.5 g/kg octagam 10% eve...    OG006  NCT00812565   \n",
       "..                                                 ...      ...          ...   \n",
       "186  Subjects assigned to warfarin therapy.\\n\\nWarf...    OG001  NCT01182441   \n",
       "187  Warfarin tablets plus placebo Edoxaban tablets...    OG002  NCT00781391   \n",
       "188                                  ZOMIG nasal spray    OG001  NCT01211145   \n",
       "189                                  ZOMIG nasal spray    OG002  NCT01211145   \n",
       "190                                  ZOMIG nasal spray    OG003  NCT01211145   \n",
       "\n",
       "                        treat_and_dose  \n",
       "0                   Octagam @ 0.1 g/kg  \n",
       "1                   Octagam @ 0.2 g/kg  \n",
       "2                  Octagam @ 0.25 g/kg  \n",
       "3                   Octagam @ 0.4 g/kg  \n",
       "4                   Octagam @ 0.5 g/kg  \n",
       "..                                 ...  \n",
       "186                     Warfarin @ NaN  \n",
       "187  Placebo @ NaN \\n\\n Warfarin @ NaN  \n",
       "188                     Zomig @ 0.5 mg  \n",
       "189                     Zomig @ 2.5 mg  \n",
       "190                       Zomig @ 5 mg  \n",
       "\n",
       "[191 rows x 5 columns]"
      ]
     },
     "execution_count": 117,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "labeled_admins"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "id": "1bbb0375",
   "metadata": {},
   "outputs": [],
   "source": [
    "# prep data for GPT3\n",
    "\n",
    "labeled_admins['title_and_desc'] = 'title: '\\\n",
    "    + labeled_admins['title']\\\n",
    "    + ' $ description: '\\\n",
    "    + labeled_admins['description']\\\n",
    "    + '\\n\\n###\\n\\n'\\\n",
    "\n",
    "labeled_admins['treat_and_dose'] = ' ' + labeled_admins['treat_and_dose'] + ' ###'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "id": "f2644dba",
   "metadata": {},
   "outputs": [],
   "source": [
    "train = labeled_admins.rename(columns = {\n",
    "    'title_and_desc': 'prompt',\n",
    "    'treat_and_dose': 'completion'\n",
    "})[['prompt', 'completion']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "id": "aa56dedb",
   "metadata": {},
   "outputs": [],
   "source": [
    "train.to_json('data.jsonl', orient='records', lines=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2de9a336",
   "metadata": {},
   "outputs": [],
   "source": [
    "train"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "15c0e407",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Found potentially duplicated files with name 'data.jsonl', purpose 'fine-tune' and size 56195 bytes\n",
      "file-RnFXbe2lnpmxol7r9iG4LOTG\n",
      "file-56w0yf1jGAZZVuRpSPWCYI9N\n",
      "file-NQT7heIzs1x5DX43x5SdCQRa\n",
      "file-BynuKtlSUbE0pGWnfbl1c3ET\n",
      "Enter file ID to reuse an already uploaded file, or an empty string to upload this file anyway: ^C\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Train model\n",
    "!export default OPENAI_API_KEY='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'\n",
    "!echo $OPENAI_API_KEY\n",
    "!openai -k 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 api  fine_tunes.create -t data.jsonl -m davinci \n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6667da18",
   "metadata": {},
   "source": [
    "### Just Treatments\n",
    "- Let's look at just treatments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 208,
   "id": "3eada5e9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>Treatment</th>\n",
       "      <th>Dosage</th>\n",
       "      <th>description</th>\n",
       "      <th>study_id</th>\n",
       "      <th>study</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Clobazam High Dose</td>\n",
       "      <td>Clobazam</td>\n",
       "      <td>5 to 40 mg</td>\n",
       "      <td>5 to 40 mg/day with doses in the morning and a...</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT00162981</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Clobazam Low Dose</td>\n",
       "      <td>Clobazam</td>\n",
       "      <td>5 to 10 mg</td>\n",
       "      <td>5 to 10 mg/day with doses in the morning and a...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT00162981</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Intranasal Midazolam</td>\n",
       "      <td>Midazolam</td>\n",
       "      <td>0.2 mg</td>\n",
       "      <td>0.2 mg/kg Intranasal Midazolam for a seizure l...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT00326612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Intranasal Midazolam</td>\n",
       "      <td>Midazolam</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients who required oxygen at discharge from...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT00326612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Rectal Diazepam</td>\n",
       "      <td>Diazepam</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Includes intubation</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT00326612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>Pembrolizumab + Epacadostat</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>200 mg</td>\n",
       "      <td>Participants received pembrolizumab 200 mg as ...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT03322540</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients receiving celebrex preoperative and p...</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients receiving scheduled ketorolac postope...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>Celecoxib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Participants</td>\n",
       "      <td>OG001</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>Ketorolac</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Participants</td>\n",
       "      <td>OG000</td>\n",
       "      <td>NCT03331315</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>278 rows Ã— 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                           title      Treatment      Dosage  \\\n",
       "0             Clobazam High Dose       Clobazam  5 to 40 mg   \n",
       "1              Clobazam Low Dose       Clobazam  5 to 10 mg   \n",
       "2           Intranasal Midazolam      Midazolam      0.2 mg   \n",
       "3           Intranasal Midazolam      Midazolam         NaN   \n",
       "4                Rectal Diazepam       Diazepam         NaN   \n",
       "..                           ...            ...         ...   \n",
       "273  Pembrolizumab + Epacadostat  Pembrolizumab      200 mg   \n",
       "274                    Celecoxib      Celecoxib         NaN   \n",
       "275                    Ketorolac      Ketorolac         NaN   \n",
       "276                    Celecoxib      Celecoxib         NaN   \n",
       "277                    Ketorolac      Ketorolac         NaN   \n",
       "\n",
       "                                           description study_id        study  \n",
       "0    5 to 40 mg/day with doses in the morning and a...    OG001  NCT00162981  \n",
       "1    5 to 10 mg/day with doses in the morning and a...    OG000  NCT00162981  \n",
       "2    0.2 mg/kg Intranasal Midazolam for a seizure l...    OG000  NCT00326612  \n",
       "3    Patients who required oxygen at discharge from...    OG000  NCT00326612  \n",
       "4                                  Includes intubation    OG001  NCT00326612  \n",
       "..                                                 ...      ...          ...  \n",
       "273  Participants received pembrolizumab 200 mg as ...    OG000  NCT03322540  \n",
       "274  Patients receiving celebrex preoperative and p...    OG001  NCT03331315  \n",
       "275  Patients receiving scheduled ketorolac postope...    OG000  NCT03331315  \n",
       "276                                       Participants    OG001  NCT03331315  \n",
       "277                                       Participants    OG000  NCT03331315  \n",
       "\n",
       "[278 rows x 6 columns]"
      ]
     },
     "execution_count": 208,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "labeled_admins = pd.read_csv('admin_labels_labeled.csv')\n",
    "labeled_admins = labeled_admins.drop(labeled_admins.columns[0], axis=1).fillna(value='NaN')\n",
    "labeled_admins"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 209,
   "id": "94ace723",
   "metadata": {},
   "outputs": [],
   "source": [
    "labeled_admins['Treatment'] = labeled_admins['Treatment'].str.lower()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 210,
   "id": "aaad9a4b",
   "metadata": {},
   "outputs": [],
   "source": [
    "labeled_admins = labeled_admins.groupby(['title', 'description', 'study_id', 'study']).agg({\n",
    "    'Treatment': lambda x: ', '.join(x),\n",
    "}).reset_index()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 211,
   "id": "ab9aa9ee",
   "metadata": {},
   "outputs": [],
   "source": [
    "labeled_admins['title_and_desc'] = '*title*: '\\\n",
    "    + labeled_admins['title']\\\n",
    "    + ' *description*: '\\\n",
    "    + labeled_admins['description']\\\n",
    "    + '\\n\\n$$$\\n\\n'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 212,
   "id": "2d74e1b6",
   "metadata": {},
   "outputs": [],
   "source": [
    "train = labeled_admins.rename(columns = {\n",
    "    'title_and_desc': 'prompt',\n",
    "    'Treatment': 'completion'\n",
    "})[['prompt', 'completion']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 213,
   "id": "5633faa2",
   "metadata": {},
   "outputs": [],
   "source": [
    "train['completion'] = ' *treatments given*: ' + train['completion'] + ' %%%'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 214,
   "id": "ac2751b3",
   "metadata": {},
   "outputs": [],
   "source": [
    "train.to_json('treat_data_2.jsonl', orient='records', lines=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "afe01ff6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "id": "67c1bf30",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<OpenAIObject text_completion id=cmpl-6ZmzyLk0XI8sGUsA1K0yodQMWGuVG at 0x16e69d310> JSON: {\n",
       "  \"choices\": [\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 0,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \" Prednisolone @ NaN \\n\\n Prednisone @ NaN ###\"\n",
       "    }\n",
       "  ],\n",
       "  \"created\": 1673987850,\n",
       "  \"id\": \"cmpl-6ZmzyLk0XI8sGUsA1K0yodQMWGuVG\",\n",
       "  \"model\": \"curie:ft-the-medical-board-2023-01-17-19-44-57\",\n",
       "  \"object\": \"text_completion\",\n",
       "  \"usage\": {\n",
       "    \"completion_tokens\": 16,\n",
       "    \"prompt_tokens\": 88,\n",
       "    \"total_tokens\": 104\n",
       "  }\n",
       "}"
      ]
     },
     "execution_count": 88,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "openai.Completion.create(\n",
    "    model='curie:ft-the-medical-board-2023-01-17-19-44-57',\n",
    "    prompt='title: Placebo q2w\\n description: 2 subcutaneous injections of Placebo (for Dupilumab) as a loading dose on Day 1, followed by a single injection q2w for 24 weeks in combination with OCS - (prednisone or prednisolone) and stable ICS. OCS dose was reduced according to a predetermined titration schedule every 4 weeks until Week 20.\\n\\n###\\n\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "id": "85ca32b6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<OpenAIObject text_completion id=cmpl-6Zn2Dusq9udqH5MKiz34cEohuDPlU at 0x16e69d7f0> JSON: {\n",
       "  \"choices\": [\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 0,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \" Placebo @ NaN ###\\n\\n E2006 @ NaN ###\\n\\n Placebo\"\n",
       "    }\n",
       "  ],\n",
       "  \"created\": 1673987989,\n",
       "  \"id\": \"cmpl-6Zn2Dusq9udqH5MKiz34cEohuDPlU\",\n",
       "  \"model\": \"curie:ft-the-medical-board-2023-01-17-19-44-57\",\n",
       "  \"object\": \"text_completion\",\n",
       "  \"usage\": {\n",
       "    \"completion_tokens\": 16,\n",
       "    \"prompt_tokens\": 45,\n",
       "    \"total_tokens\": 61\n",
       "  }\n",
       "}"
      ]
     },
     "execution_count": 89,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "openai.Completion.create(\n",
    "    model='curie:ft-the-medical-board-2023-01-17-19-44-57',\n",
    "    prompt='title: Part A: E2006 Matched Placebo\\n description: Healthy participants received E2006-matched placebo, capsule, orally in the morning, one hour after lights-on, on Day 1.\\n\\n###\\n\\n')\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff663fd7",
   "metadata": {},
   "source": [
    "# Prod Pipeline\n",
    "\n",
    "- Pipeline to get the treatments out of groups"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "id": "b23281ef",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sqlalchemy import create_engine\n",
    "\n",
    "db = create_engine(\"postgresql://meditreats:meditreats@df-treats-db.cs6hxh6ocizm.us-west-2.rds.amazonaws.com:5432/meditreats\")\n",
    "\n",
    "connection = db.connect()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "3963d93b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Query groups then do NER\n",
    "groups = pd.read_sql(\"select * from groups\", connection)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 187,
   "id": "20411160",
   "metadata": {},
   "outputs": [],
   "source": [
    "groups['prompt'] = 'title: ' + groups['title'] + ' $ description: ' + groups['description'] + ' \\n\\n###\\n\\n\"'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "id": "ff1836ee",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4909"
      ]
     },
     "execution_count": 169,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(groups.index) // 20"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 171,
   "id": "546d3d11",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0       21\n",
       "5       21\n",
       "1       21\n",
       "7       21\n",
       "6       21\n",
       "        ..\n",
       "1640    20\n",
       "1639    20\n",
       "1638    20\n",
       "1637    20\n",
       "4908    20\n",
       "Name: batch_group, Length: 4909, dtype: int64"
      ]
     },
     "execution_count": 171,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "groups['batch_group'] = groups.index % (len(groups.index) // 20)\n",
    "groups['batch_group'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 178,
   "id": "b5540f2f",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/_s/43vfll7573v29r_276tsvdzc0000gn/T/ipykernel_7024/2250897815.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  groups[groups['batch_group'] == 2]['hello'] = groups[groups['batch_group'] == 2]['title'].apply(lambda x: x[0])\n"
     ]
    }
   ],
   "source": [
    "groups[groups['batch_group'] == 2]['hello'] = groups[groups['batch_group'] == 2]['title'].apply(lambda x: x[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 179,
   "id": "64dfd601",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>title</th>\n",
       "      <th>study_id</th>\n",
       "      <th>description</th>\n",
       "      <th>study</th>\n",
       "      <th>annotated</th>\n",
       "      <th>prompt</th>\n",
       "      <th>batch_group</th>\n",
       "      <th>hello</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Arm I</td>\n",
       "      <td>OG000</td>\n",
       "      <td>Patients receive oral vorinostat twice daily o...</td>\n",
       "      <td>NCT00262834</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Arm I \\n description: Patients receive ...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4911</th>\n",
       "      <td>4866</td>\n",
       "      <td>Single Arm - Transplant Pre-conditioning Per S...</td>\n",
       "      <td>OG000</td>\n",
       "      <td>Conditioning with Alemtuzumab, busulfan and fl...</td>\n",
       "      <td>NCT00301834</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Single Arm - Transplant Pre-conditionin...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9820</th>\n",
       "      <td>9752</td>\n",
       "      <td>Part 1: Conversion</td>\n",
       "      <td>OG000</td>\n",
       "      <td>Subjects converted from their previous CD-LD t...</td>\n",
       "      <td>NCT01411137</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Part 1: Conversion \\n description: Subj...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14729</th>\n",
       "      <td>14651</td>\n",
       "      <td>Dexamethasone Group</td>\n",
       "      <td>OG000</td>\n",
       "      <td>0.5% Bupivacaine with 1:200,000epinephrine + D...</td>\n",
       "      <td>NCT01975285</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Dexamethasone Group \\n description: 0.5...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19638</th>\n",
       "      <td>19526</td>\n",
       "      <td>OA Participants</td>\n",
       "      <td>OG000</td>\n",
       "      <td>Participants with OA who responded to the WOMA...</td>\n",
       "      <td>NCT01430559</td>\n",
       "      <td>None</td>\n",
       "      <td>title: OA Participants \\n description: Partici...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24547</th>\n",
       "      <td>24413</td>\n",
       "      <td>Dose Dense TC + Pegfilgrastim</td>\n",
       "      <td>OG000</td>\n",
       "      <td>Docetaxel + Cyclophosphamide chemotherapy give...</td>\n",
       "      <td>NCT01671319</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Dose Dense TC + Pegfilgrastim \\n descri...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29456</th>\n",
       "      <td>29385</td>\n",
       "      <td>Phase Ia: Afatinib 20mg+Trastuzumab 8 mg/kg</td>\n",
       "      <td>OG000</td>\n",
       "      <td>In each 21 day treatment cycle, patients were ...</td>\n",
       "      <td>NCT01649271</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Phase Ia: Afatinib 20mg+Trastuzumab 8 m...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34365</th>\n",
       "      <td>34252</td>\n",
       "      <td>Asacol</td>\n",
       "      <td>OG001</td>\n",
       "      <td>1.6g/day administered 800 mg BID</td>\n",
       "      <td>NCT00151892</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Asacol \\n description: 1.6g/day adminis...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39274</th>\n",
       "      <td>39189</td>\n",
       "      <td>Midazolam</td>\n",
       "      <td>OG001</td>\n",
       "      <td>Subjects who are randomized to be on this grou...</td>\n",
       "      <td>NCT02522377</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Midazolam \\n description: Subjects who ...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44183</th>\n",
       "      <td>44116</td>\n",
       "      <td>Dysport NG 50 U</td>\n",
       "      <td>OG002</td>\n",
       "      <td>Botulinum type A toxin (Dysport RU), Intramusc...</td>\n",
       "      <td>NCT01333397</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Dysport NG 50 U \\n description: Botulin...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49092</th>\n",
       "      <td>49038</td>\n",
       "      <td>GSK256066 1 mcg</td>\n",
       "      <td>OG001</td>\n",
       "      <td>Eligible participants received a single dose o...</td>\n",
       "      <td>NCT00464568</td>\n",
       "      <td>None</td>\n",
       "      <td>title: GSK256066 1 mcg \\n description: Eligibl...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54001</th>\n",
       "      <td>53941</td>\n",
       "      <td>Figitumumab 20 mg/kg RP2D Expansion 1.0 Infusion</td>\n",
       "      <td>OG003</td>\n",
       "      <td>The RP2D of figitumumab 20 mg/kg was administe...</td>\n",
       "      <td>NCT00560573</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Figitumumab 20 mg/kg RP2D Expansion 1.0...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58910</th>\n",
       "      <td>58850</td>\n",
       "      <td>Acyline + Testosterone Gel + Placebo</td>\n",
       "      <td>OG000</td>\n",
       "      <td>300mcg Acyline, 1% testosterone gel 5g daily +...</td>\n",
       "      <td>NCT01215292</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Acyline + Testosterone Gel + Placebo \\n...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63819</th>\n",
       "      <td>63795</td>\n",
       "      <td>150 mg od</td>\n",
       "      <td>OG000</td>\n",
       "      <td>AZD0837 150 mg od</td>\n",
       "      <td>NCT00684307</td>\n",
       "      <td>None</td>\n",
       "      <td>title: 150 mg od \\n description: AZD0837 150 m...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68728</th>\n",
       "      <td>68720</td>\n",
       "      <td>Single Intervention</td>\n",
       "      <td>OG000</td>\n",
       "      <td>Patients received 60 Gy of Intensity Modulated...</td>\n",
       "      <td>NCT01530997</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Single Intervention \\n description: Pat...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73637</th>\n",
       "      <td>73622</td>\n",
       "      <td>Post-Other Surgery Macular Edema- Group 1</td>\n",
       "      <td>OG002</td>\n",
       "      <td>Patients who developed cystoid macular edema (...</td>\n",
       "      <td>NCT01769352</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Post-Other Surgery Macular Edema- Group...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78546</th>\n",
       "      <td>78543</td>\n",
       "      <td>CAT-354 10 mg/kg</td>\n",
       "      <td>OG002</td>\n",
       "      <td>CAT-354 5 mg/kg of body weight intravenous inf...</td>\n",
       "      <td>NCT00640016</td>\n",
       "      <td>None</td>\n",
       "      <td>title: CAT-354 10 mg/kg \\n description: CAT-35...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83455</th>\n",
       "      <td>83474</td>\n",
       "      <td>Carbamazepine ER Tablet</td>\n",
       "      <td>OG006</td>\n",
       "      <td>Subjects who received Carbamazepine ER Tablet ...</td>\n",
       "      <td>NCT02707965</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Carbamazepine ER Tablet \\n description:...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88364</th>\n",
       "      <td>88428</td>\n",
       "      <td>Placebo-Apremilast 20 mg BID</td>\n",
       "      <td>OG003</td>\n",
       "      <td>Participants who were initially randomized to ...</td>\n",
       "      <td>NCT00773734</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Placebo-Apremilast 20 mg BID \\n descrip...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93273</th>\n",
       "      <td>93351</td>\n",
       "      <td>Colposcopic Findings After 7 Days of Product Use</td>\n",
       "      <td>OG001</td>\n",
       "      <td>Number of colposcopic findings identified duri...</td>\n",
       "      <td>NCT01283555</td>\n",
       "      <td>None</td>\n",
       "      <td>title: Colposcopic Findings After 7 Days of Pr...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98182</th>\n",
       "      <td>58689</td>\n",
       "      <td>Placebo</td>\n",
       "      <td>OG000</td>\n",
       "      <td>Placebo to ZOMIG nasal spray</td>\n",
       "      <td>NCT01211145</td>\n",
       "      <td>True</td>\n",
       "      <td>title: Placebo \\n description: Placebo to ZOMI...</td>\n",
       "      <td>2</td>\n",
       "      <td>a</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          id                                              title study_id  \\\n",
       "2          2                                              Arm I    OG000   \n",
       "4911    4866  Single Arm - Transplant Pre-conditioning Per S...    OG000   \n",
       "9820    9752                                 Part 1: Conversion    OG000   \n",
       "14729  14651                                Dexamethasone Group    OG000   \n",
       "19638  19526                                    OA Participants    OG000   \n",
       "24547  24413                      Dose Dense TC + Pegfilgrastim    OG000   \n",
       "29456  29385        Phase Ia: Afatinib 20mg+Trastuzumab 8 mg/kg    OG000   \n",
       "34365  34252                                             Asacol    OG001   \n",
       "39274  39189                                          Midazolam    OG001   \n",
       "44183  44116                                    Dysport NG 50 U    OG002   \n",
       "49092  49038                                    GSK256066 1 mcg    OG001   \n",
       "54001  53941   Figitumumab 20 mg/kg RP2D Expansion 1.0 Infusion    OG003   \n",
       "58910  58850               Acyline + Testosterone Gel + Placebo    OG000   \n",
       "63819  63795                                          150 mg od    OG000   \n",
       "68728  68720                                Single Intervention    OG000   \n",
       "73637  73622          Post-Other Surgery Macular Edema- Group 1    OG002   \n",
       "78546  78543                                   CAT-354 10 mg/kg    OG002   \n",
       "83455  83474                            Carbamazepine ER Tablet    OG006   \n",
       "88364  88428                       Placebo-Apremilast 20 mg BID    OG003   \n",
       "93273  93351   Colposcopic Findings After 7 Days of Product Use    OG001   \n",
       "98182  58689                                            Placebo    OG000   \n",
       "\n",
       "                                             description        study  \\\n",
       "2      Patients receive oral vorinostat twice daily o...  NCT00262834   \n",
       "4911   Conditioning with Alemtuzumab, busulfan and fl...  NCT00301834   \n",
       "9820   Subjects converted from their previous CD-LD t...  NCT01411137   \n",
       "14729  0.5% Bupivacaine with 1:200,000epinephrine + D...  NCT01975285   \n",
       "19638  Participants with OA who responded to the WOMA...  NCT01430559   \n",
       "24547  Docetaxel + Cyclophosphamide chemotherapy give...  NCT01671319   \n",
       "29456  In each 21 day treatment cycle, patients were ...  NCT01649271   \n",
       "34365                   1.6g/day administered 800 mg BID  NCT00151892   \n",
       "39274  Subjects who are randomized to be on this grou...  NCT02522377   \n",
       "44183  Botulinum type A toxin (Dysport RU), Intramusc...  NCT01333397   \n",
       "49092  Eligible participants received a single dose o...  NCT00464568   \n",
       "54001  The RP2D of figitumumab 20 mg/kg was administe...  NCT00560573   \n",
       "58910  300mcg Acyline, 1% testosterone gel 5g daily +...  NCT01215292   \n",
       "63819                                  AZD0837 150 mg od  NCT00684307   \n",
       "68728  Patients received 60 Gy of Intensity Modulated...  NCT01530997   \n",
       "73637  Patients who developed cystoid macular edema (...  NCT01769352   \n",
       "78546  CAT-354 5 mg/kg of body weight intravenous inf...  NCT00640016   \n",
       "83455  Subjects who received Carbamazepine ER Tablet ...  NCT02707965   \n",
       "88364  Participants who were initially randomized to ...  NCT00773734   \n",
       "93273  Number of colposcopic findings identified duri...  NCT01283555   \n",
       "98182                       Placebo to ZOMIG nasal spray  NCT01211145   \n",
       "\n",
       "      annotated                                             prompt  \\\n",
       "2          None  title: Arm I \\n description: Patients receive ...   \n",
       "4911       None  title: Single Arm - Transplant Pre-conditionin...   \n",
       "9820       None  title: Part 1: Conversion \\n description: Subj...   \n",
       "14729      None  title: Dexamethasone Group \\n description: 0.5...   \n",
       "19638      None  title: OA Participants \\n description: Partici...   \n",
       "24547      None  title: Dose Dense TC + Pegfilgrastim \\n descri...   \n",
       "29456      None  title: Phase Ia: Afatinib 20mg+Trastuzumab 8 m...   \n",
       "34365      None  title: Asacol \\n description: 1.6g/day adminis...   \n",
       "39274      None  title: Midazolam \\n description: Subjects who ...   \n",
       "44183      None  title: Dysport NG 50 U \\n description: Botulin...   \n",
       "49092      None  title: GSK256066 1 mcg \\n description: Eligibl...   \n",
       "54001      None  title: Figitumumab 20 mg/kg RP2D Expansion 1.0...   \n",
       "58910      None  title: Acyline + Testosterone Gel + Placebo \\n...   \n",
       "63819      None  title: 150 mg od \\n description: AZD0837 150 m...   \n",
       "68728      None  title: Single Intervention \\n description: Pat...   \n",
       "73637      None  title: Post-Other Surgery Macular Edema- Group...   \n",
       "78546      None  title: CAT-354 10 mg/kg \\n description: CAT-35...   \n",
       "83455      None  title: Carbamazepine ER Tablet \\n description:...   \n",
       "88364      None  title: Placebo-Apremilast 20 mg BID \\n descrip...   \n",
       "93273      None  title: Colposcopic Findings After 7 Days of Pr...   \n",
       "98182      True  title: Placebo \\n description: Placebo to ZOMI...   \n",
       "\n",
       "       batch_group hello  \n",
       "2                2     a  \n",
       "4911             2     a  \n",
       "9820             2     a  \n",
       "14729            2     a  \n",
       "19638            2     a  \n",
       "24547            2     a  \n",
       "29456            2     a  \n",
       "34365            2     a  \n",
       "39274            2     a  \n",
       "44183            2     a  \n",
       "49092            2     a  \n",
       "54001            2     a  \n",
       "58910            2     a  \n",
       "63819            2     a  \n",
       "68728            2     a  \n",
       "73637            2     a  \n",
       "78546            2     a  \n",
       "83455            2     a  \n",
       "88364            2     a  \n",
       "93273            2     a  \n",
       "98182            2     a  "
      ]
     },
     "execution_count": 179,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "groups[groups['batch_group'] == 2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 186,
   "id": "104ce2f0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['title: Vorinostat \\n description: Women in the vorinostat group were scheduled to receive 6 doses of oral vorinostat at 300 mg twice daily (bid), with the last dose administered by study personnel approximately 2 hours before the scheduled breast surgery (or biopsy). \\n\\n###\\n\\n\"',\n",
       " 'title: Tissue Only \\n description: Women who declined vorinostat but agreed to donate tissues for biomarker assessment, signed a separate informed consent and were enrolled as controls. \\n\\n###\\n\\n\"',\n",
       " 'title: Arm I \\n description: Patients receive oral vorinostat twice daily on days -3 to 0. Approximately 2 hours after the final dose of vorinostat, patients undergo conventional surgery of the tumor on day 0. After completion of study treatment, patients are followed for 30 days.\\n\\nvorinostat: Given orally, conventional surgery to follow.\\n\\nconventional surgery: Undergo conventional surgery \\n\\n###\\n\\n\"',\n",
       " 'title: Low CIWA Flumazenil/Gabapentin \\n description: 2 mg flumazenil given over 20 minutes on Day 1 and Day 2. Gabapentin 300 mg Day 1; gabapentin 600 mg Day 2; gabapentin 900 mg Day 3; gabapentin 1200 mg Day 4 to 30; gabapentin 900 mg day 31-33; gabapentin 600 mg day 34-36; gabapentin 300 mg day 37-39. \\n\\n###\\n\\n\"',\n",
       " 'title: Low CIWAar Placebo \\n description: 20 mg Saline infused slowly over 20 minutes. Placebo 1 capsule Day 1, 2 capsules Day 2, 3 capsules Day 3, 4 capsules days 4 to 30; 3 capsules Day 31 to 33; 2 capsules day 34 to 36 and 1 capsule 37 to 39. \\n\\n###\\n\\n\"',\n",
       " 'title: High CIWAar Placebo \\n description: 20 mg Saline infused slowly over 20 minutes. Placebo 1 capsule Day 1, 2 capsules Day 2, 3 capsules Day 3, 4 capsules days 4 to 30; 3 capsules Day 31 to 33; 2 capsules day 34 to 36 and 1 capsule 37 to 39. \\n\\n###\\n\\n\"',\n",
       " 'title: High CIWAar Flumazenil/Gabapentin \\n description: 2 mg flumazenil given over 20 minutes on Day 1 and Day 2. Gabapentin 300 mg Day 1; gabapentin 600 mg Day 2; gabapentin 900 mg Day 3; gabapentin 1200 mg Day 4 to 30; gabapentin 900 mg day 31-33; gabapentin 600 mg day 34-36; gabapentin 300 mg day 37-39. \\n\\n###\\n\\n\"',\n",
       " 'title: Ruboxistaurin \\n description: 32 mg given once daily as oral tablet for 2 years. \\n\\n###\\n\\n\"',\n",
       " 'title: Pancreatic Adenocarcinoma Patients \\n description: Pancreatic Adenocarcinoma Patients treated with chemotherapy regimen and radiation (and or surgery). Patients will be given one cycle of continuous infusion 5-FU (175 mg/m^2/day for 38 days), weekly cisplatin 30 mg/m^2 over 1 hour, and IFN-alpha-2b (3 million units given subcutaneously on days 1, 3, and 5 of each week for 5Â½ weeks) with radiation therapy (5040 cGy total, in 28 fractions, at 180 cGy/fraction daily, Monday -Friday, for 5Â½ weeks) followed by two cycles of bolus 5-FU alone (500 mg/m^2 weekly * 6, followed by 2 weeks of rest). \\n\\n###\\n\\n\"',\n",
       " 'title: Early Treated \\n description: Humatrope administered according to investigator\\'s clinical practice and guided by the approved package insert.\\n\\nHumatrope administered in B9R-US-GDFG (NCT00406926). \\n\\n###\\n\\n\"',\n",
       " 'title: Early Untreated \\n description: Humatrope administered according to investigator\\'s clinical practice and guided by the approved package insert.\\n\\nControl: Humatrope was not administered in B9R-US-GDFG (NCT00406926). \\n\\n###\\n\\n\"',\n",
       " 'title: Group A: Ibuprofen Alone \\n description: Time 0 Ibuprofen (10mg/kg)given. Temperature in Â°C measured hourly for 6 hours. \\n\\n###\\n\\n\"',\n",
       " 'title: Group B: Ibuprofen and Acetaminophen \\n description: time 0 child Ibuprofen (10mg/kg) and Acetaminophen (15 mg/kg)given. Temperature in Â°C measured hourly for 6 hours. \\n\\n###\\n\\n\"',\n",
       " 'title: Group C: Ibuprofen Then Acetaminophen \\n description: Time 0 child is given Ibuprofen (10mg/kg) and at time 3 hours is given (15 mg/kg. Temperature in Â°C measured hourly for 6 hours. \\n\\n###\\n\\n\"',\n",
       " 'title: Zoledronic Acid \\n description: 3.0-4.0 mg by IV (in the vein), once a month for 6 months \\n\\n###\\n\\n\"',\n",
       " 'title: Group I: Placebo \\n description: Placebo SC injections every 4 weeks (wks) from Week (Wk) 0 thru Wk 20 (unless early escape at Wk 16); golimumab - if early escape, 50 mg SC every 4 wks from Wk 16 up to 5 yrs; golimumab - 50 mg SC beginning Wk 24 up to 5 yrs (unless early escape); golimumab- Dr\\'s discretion after unblinding, dose adjust from 50 to 100 mg. \\n\\n###\\n\\n\"',\n",
       " 'title: Group II: Golimumab 50 mg \\n description: Golimumab 50 mg SC injections every 4 wks from Wk 0 thru 5 yrs (unless early escape at Wk 16); golimumab - If early escape, 100 mg SC every 4 wks beginning Wk 16 up to 5 yrs; golimumab - Dr\\'s discretion after unblinding, dose adjust from 50 to 100 mg. \\n\\n###\\n\\n\"',\n",
       " 'title: Group III: Golimumab 100 mg \\n description: Golimumab 100 mg SC injections every 4 wks from Wk 0 up to 5 yrs. \\n\\n###\\n\\n\"',\n",
       " 'title: Combined: Groups II & III \\n description: Combines Group II (golimumab 50 mg) and Group III (golimumab 100 mg). \\n\\n###\\n\\n\"',\n",
       " 'title: PROCRIT 40,000 IU QW \\n description: Epoetin alpha (PROCRIT) 40,000 IU every week (QW) for 18 weeks (intravenous or subcutaneous) \\n\\n###\\n\\n\"']"
      ]
     },
     "execution_count": 186,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "groups['prompt'][:20].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 188,
   "id": "9269a47c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# batch 20 prompts in a requsts\n",
    "response = openai.Completion.create(\n",
    "    model=\"davinci:ft-the-medical-board-2023-01-17-22-38-25\",\n",
    "    prompt=groups['prompt'][:20].tolist(),\n",
    ")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 189,
   "id": "72cbb759",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<OpenAIObject text_completion id=cmpl-6ZpDlohbiFS3jmZxfmascRITTPxmR at 0x1709e4770> JSON: {\n",
       "  \"choices\": [\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 0,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"vorinostat\\\" ###\\n\\n vorinostat ###\\n\\n medication ###\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 1,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"Tissues Only\\\" ###\\n\\n vorinostat ### controls ### tissue ###\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 2,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"vorinostat\\\"\\n\\n\\\"conventional surgery\\\"\\n\\n###\\n\\n\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 3,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"flumazenil\\\" \\n\\n\\\"gabapentin\\\" ###\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 4,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"placebo\\\" ###\\n\\n placebo ### low ### ciwa ###\\n\\nSal\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 5,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"placebo\\\" ###\\n\\n saline ###\\n\\n ###\\n\\n###\\n\\n placebo ###\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 6,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"flumazenil\\\" \\n\\n\\\"gabapentin\\\" ###\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 7,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"ruboxistaurin\\\" ###\\n\\n ruboxistaurin ###\\n\\n ###\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 8,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"cisplatin \\n\\n\\nifn-alpha-2b \\n\\n\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 9,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"humatrope\\\" ### tdros ### \\n\\nb9r-\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 10,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"Humatrope\\\" ###\\n\\n b9r-us-gdfg\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 11,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"ibuprofen\\\" ###\\n\\n ibuprofen ###\\n\\n ###\\n\\n ib\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 12,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"ibuprofen\\\" \\n\\n\\\"acetaminophen\\\" ###\\n\\n ib\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 13,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"Ibuprofen\\\" \\n\\n\\\"acetaminophen\\\" ###\\n\\n\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 14,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"zoledronic acid\\\" ###\\n\\n zoledronic acid ###\\n\\n ###\\n\\n val\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 15,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"golimumab\\\" \\n\\n\\\"placebo\\\" ###\\n\\n golimum\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 16,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"golimumab\\\" ###\\n\\n golimumab ###\\n\\n diabetes ###\\n\\n gol\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 17,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"golimumab\\\" ###\\n\\n golimumab ###\\n\\n consensus ###\\n\\n nan\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 18,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"Golimumab\\\" ###\\n\\n golimumab ###\\n\\n combine groups ii and\"\n",
       "    },\n",
       "    {\n",
       "      \"finish_reason\": \"length\",\n",
       "      \"index\": 19,\n",
       "      \"logprobs\": null,\n",
       "      \"text\": \"procrit\\\" ###\\n\\n procrit ###\\n\\n qw ###\\n\\n 18 weeks ###\"\n",
       "    }\n",
       "  ],\n",
       "  \"created\": 1673996393,\n",
       "  \"id\": \"cmpl-6ZpDlohbiFS3jmZxfmascRITTPxmR\",\n",
       "  \"model\": \"davinci:ft-the-medical-board-2023-01-17-22-38-25\",\n",
       "  \"object\": \"text_completion\",\n",
       "  \"usage\": {\n",
       "    \"completion_tokens\": 320,\n",
       "    \"prompt_tokens\": 1442,\n",
       "    \"total_tokens\": 1762\n",
       "  }\n",
       "}"
      ]
     },
     "execution_count": 189,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 190,
   "id": "a88c3fae",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['vorinostat\" ###\\n\\n vorinostat ###\\n\\n medication ###',\n",
       " 'Tissues Only\" ###\\n\\n vorinostat ### controls ### tissue ###',\n",
       " 'vorinostat\"\\n\\n\"conventional surgery\"\\n\\n###\\n\\n',\n",
       " 'flumazenil\" \\n\\n\"gabapentin\" ###',\n",
       " 'placebo\" ###\\n\\n placebo ### low ### ciwa ###\\n\\nSal',\n",
       " 'placebo\" ###\\n\\n saline ###\\n\\n ###\\n\\n###\\n\\n placebo ###',\n",
       " 'flumazenil\" \\n\\n\"gabapentin\" ###',\n",
       " 'ruboxistaurin\" ###\\n\\n ruboxistaurin ###\\n\\n ###',\n",
       " 'cisplatin \\n\\n\\nifn-alpha-2b \\n\\n',\n",
       " 'humatrope\" ### tdros ### \\n\\nb9r-',\n",
       " 'Humatrope\" ###\\n\\n b9r-us-gdfg',\n",
       " 'ibuprofen\" ###\\n\\n ibuprofen ###\\n\\n ###\\n\\n ib',\n",
       " 'ibuprofen\" \\n\\n\"acetaminophen\" ###\\n\\n ib',\n",
       " 'Ibuprofen\" \\n\\n\"acetaminophen\" ###\\n\\n',\n",
       " 'zoledronic acid\" ###\\n\\n zoledronic acid ###\\n\\n ###\\n\\n val',\n",
       " 'golimumab\" \\n\\n\"placebo\" ###\\n\\n golimum',\n",
       " 'golimumab\" ###\\n\\n golimumab ###\\n\\n diabetes ###\\n\\n gol',\n",
       " 'golimumab\" ###\\n\\n golimumab ###\\n\\n consensus ###\\n\\n nan',\n",
       " 'Golimumab\" ###\\n\\n golimumab ###\\n\\n combine groups ii and',\n",
       " 'procrit\" ###\\n\\n procrit ###\\n\\n qw ###\\n\\n 18 weeks ###']"
      ]
     },
     "execution_count": 190,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[x['text'] for x in response['choices']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "id": "1497de39",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Vorinostat @ 300 mg bid\" ###\\n\\n Vorinostat',\n",
       " 'Vorinostat @ NaN \\n\\n Tissues @ NaN\"',\n",
       " 'vorinostat @ NaN mg\" \\n\\n\\n\"conventional surgery',\n",
       " 'Flumazenil @ 2 mg\" \\n\\n\"Gabapentin',\n",
       " 'Placebo @ 20 mg\" \\n ###\\n\\n Saline @ 20 mg ###',\n",
       " 'Saline @ NaN\" \\n\\n Placebo @ NaN ###\\n\\n',\n",
       " 'Flumazenil @ 2 mg \\n\\n Gabapentin @ 600 mg',\n",
       " 'Ruboxistaurin\" @ 32 mg ###\\n\\n###\\n\\n Rubox',\n",
       " '5-FU @ 175 mg/m^2\" \\n\"Cis',\n",
       " 'Humatrope @ B9R-US-GDFG\" @',\n",
       " 'Humatrope @ NaN \\n\\n Humatrope @ NaN ###',\n",
       " 'Ibuprofen @ 10mg/kg\" ###\\n\\n Ibupro',\n",
       " 'Ibuprofen @ 10 mg/kg\" \\n\"Acet',\n",
       " 'Ibuprofen @ 10 mg/kg\" \\n \"Acet',\n",
       " 'Zoledronic Acid @ 3.0 to 4.0 mg ###\\n\\n\\n',\n",
       " 'Golimumab @ 50 mg â€” 100 mg\" \\n\\n Placebo @',\n",
       " 'Golimumab\" @ 50 mg \\n\\n Golimumab @ 100 mg',\n",
       " 'Golimumab @ 100 mg\" ### \\n\\n Golimumab @ 100',\n",
       " 'golimumab @ 50 mg\" \\n\"golimumab @',\n",
       " 'Procrit @ 40,000 IU\" ###\\n\\n Epoetin alpha']"
      ]
     },
     "execution_count": 154,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[x['text'] for x in response['choices']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fa0f8c8b",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
